Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement
Multidrug-resistant organism (MDRO) colonization is a fundamental challenge in antimicrobial resistance. Limited studies have shown that fecal microbiota transplantation (FMT) can reduce MDRO colonization, but its mechanisms are poorly understood. We conducted a randomized, controlled trial of FMT for MDRO decolonization in renal transplant recipients called PREMIX (NCT02922816). Eleven participants were enrolled and randomized 1:1 to FMT or an observation period followed by delayed FMT if stool cultures were MDRO positive at day 36.
The data suggest that FMT may provide a path to exploit strain competition to reduce MDRO colonization.
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!